Skip to main content
Fig. 9 | Trials

Fig. 9

From: TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial

Fig. 9

Kinetics of both TA plasma concentration and plasmin AUC in TA-treated patients: evolution of TA plasma concentration and plasmin AUC over time points: T0, T15, T30, T60, T120, T180, and T360, in six patients treated by TA (0.5, 1, or 2 g). a Kinetics of TA plasma concentration and plasmin AUC: group TA0.5 - patient 20. b Kinetics of TA plasma concentration and plasmin AUC: group TA0.5 - patient 19. c Kinetics of TA plasma concentration and plasmin AUC: group TA1 - patient 24. d Kinetics of TA plasma concentration and plasmin AUC: group TA1 - patient 25. e Kinetics of TA plasma concentration and plasmin AUC: group TA2 - patient 12. f Kinetics of TA plasma concentration and plasmin AUC: group TA2 - patient 17

Back to article page

Trials

ISSN: 1745-6215